José Belderbos is an expert in Radiotherapy at Antoni van Leeuwenhoek Hospital (Netherlands). As of October 2026, ScienceLeadR ranks José Belderbos in the top 1% of experts worldwide for Bronchial Neoplasms, Thoracic Neoplasms and Lung Neoplasms. José Belderbos has authored 253 publications, the most recent in 2026, and is an investigator in 9 clinical trials. SLR score: 877 (community average: 125). How the SLR is computed.

LeadR Profile

José Belderbos Antoni van Leeuwenhoek Hospital Netherlands
877 ScienceLeadR Reputation 877
Network Map

Radiotherapy

Subspecialties: Oncology - Pulmonology - Medical Imaging

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Organizations

Career arc: 2003 - 2026

Source: PubMed

Antoni van Leeuwenhoek Hospital

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 253

Citations

Citations: 14 590 1st author: 14 Last author: 42 Unique author: 0


Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Evaluation of Cardiac Function After Stereotactic Body Radiation Therapy for Lung Tumors: Results of the Prospective Explorative Heart-Lung Study.
PMID 42824061 — radiotherapy, pilot projects, pilots, lung, laboratories, heart, neoplasms, carcinoma, non-small-cell lung, echocardiography, therapeutics, electrocardiography, myocardial strain
Adv Radiat Oncol20260
Patient-reported symptom monitoring in patients with lung cancer (SYMPRO-Lung trial): long-term, post-hoc survival results of a multicentre, stepped-wedged, cluster-randomised clinical trial.
PMID 42727592 — quality of life, lung, progression-free survival, neoplasms, lung neoplasms, therapeutics
Lancet Oncol Top journal20260
Dose-escalated twice daily radiotherapy for limited stage small cell lung cancer: an implementation strategy in the Netherlands.
PMID 42583201 — radiotherapy, cells, lung, neoplasms, lung neoplasms, small cell lung carcinoma
J Thorac Dis20260
Real-world data on once or twice daily radiotherapy and the effect of age in patients with limited-stage small cell lung cancer.
PMID 42556587 — radiotherapy, cells, lung, neoplasms, lung neoplasms, small cell lung carcinoma
Int J Radiat Oncol Biol Phys20260
External validation of dose to heart substructures and the association with non-cancer death after SBRT in stage I-II NSCLC patients.
PMID 42503335 — radiotherapy, lung, nomograms, heart, neoplasms, carcinoma, non-small-cell lung, medical oncology
Radiother Oncol20260

Clinical Studies 9

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 3 Study Chair: 1

By phase:

N/A 4
Phase 3 3
Phase 1 2

By status:

Completed 6
Terminated 2
Unknown 1

By type:

Interventional 8
Observational 1

By Monocentric/Multicentric:

monocentric 1
multicentric2to4 3
multicentric5to9 4
multicentricup10 1

Main Topics

LeadR Networks

Main global connection map